Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Emerg Infect Dis ; 22(1): 96-9, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26690308

RESUMEN

Staphylococcus aureus strains that produce Panton-Valentine leukocidin are known to cause community infections. We describe an outbreak of skin abscesses caused by Panton-Valentine leukocidin-producing methicillin-susceptible S. aureus (clonal complex 121) in a professional rugby team in France during July 2010-February 2011. Eight team members were carriers; 7 had skin abscesses.


Asunto(s)
Toxinas Bacterianas/toxicidad , Exotoxinas/toxicidad , Leucocidinas/toxicidad , Infecciones Cutáneas Estafilocócicas/epidemiología , Adolescente , Adulto , Atletas , Brotes de Enfermedades , Fútbol Americano , Francia/epidemiología , Humanos , Masculino , Meticilina/uso terapéutico , Infecciones Cutáneas Estafilocócicas/tratamiento farmacológico , Staphylococcus aureus/efectos de los fármacos , Adulto Joven
2.
Dermatology ; 215(1): 28-35, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17587836

RESUMEN

OBJECTIVE: To describe a series of hospitalized patients with eczema craquelé (EC) and the possible correlations between clinical features of EC and cancer in an open prospective observational study. PATIENTS AND INTERVENTIONS: The study population comprised 68 consecutive patients included between January 1, 1999 and December 31, 2000 who were followed up through December 2004. All patients who had localized or generalized EC were included. Patients underwent complete clinical examinations, routine laboratory tests, chest x-rays, abdominal ultrasound, and cutaneous biopsies performed on EC. MAIN OUTCOME MEASURES AND RESULTS: Rates of EC associated with cancer, clinical features of eczema, rate of recalcitrant eczema, relationship to other clinical prognostic factors, and paraneoplastic evolution were evaluated. Cancer was diagnosed in 32 patients (47%). We observed a significant difference in the presenting clinical signs of EC between patients with malignant tumors and patients without cancer. In patients with malignancies, EC was widespread on the trunk and we noted deep red and inflammatory fissures. In all cases, EC led to the discovery of malignancy or recurrence of cancer. CONCLUSION: Widespread EC, topical corticosteroid resistance, and deep red and inflammatory fissures were significantly correlated with neoplasia.


Asunto(s)
Eccema/diagnóstico , Eccema/epidemiología , Neoplasias/epidemiología , Neoplasias/patología , Síndromes Paraneoplásicos/diagnóstico , Adulto , Distribución por Edad , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Comorbilidad , Estudios de Seguimiento , Humanos , Incidencia , Persona de Mediana Edad , Síndromes Paraneoplásicos/epidemiología , Valor Predictivo de las Pruebas , Estudios Prospectivos , Prurigo/diagnóstico , Prurigo/epidemiología , Índice de Severidad de la Enfermedad , Distribución por Sexo , Análisis de Supervivencia
4.
J Invest Dermatol ; 132(8): 1998-2004, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22418872

RESUMEN

A major increase in the incidence of BP has been recently reported in the United Kingdom. In addition, there are some controversies about the over-mortality of BP patients. The primary objective was to reevaluate the incidence of BP in France as compared with that we estimated 15 years ago. The secondary objective was to assess mortality of BP patients. BP incidence was retrospectively estimated from all BP cases diagnosed between January 2000 and December 2005 in three French regions with a total population of 3.858 million inhabitants. BP mortality was assessed from a prospective cohort accrued during the same time period. A total of 502 incident BP patients (mean age: 82.6±8.8 years) were identified. Overall estimated incidence was 21.7 cases per million persons per year (95%CI:19.8-23.7 cases per million persons per year), which is about 3-fold higher than the incidence that we estimated 15 years ago. In the population aged 70 years or above, BP incidence was 162 cases per million per year (95%CI:147-177 cases per million per year). The overall 1-year survival rate was 62% (95% CI: 56-67%). The risk of death for BP patients was more than six times greater than that for the general population (SMR:6.60; 95%CI:5.47-7.90). The incidence of BP in France has increased 3-fold in the last 15 years. BP is associated with high mortality.


Asunto(s)
Penfigoide Ampolloso/epidemiología , Penfigoide Ampolloso/mortalidad , Factores de Edad , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Femenino , Francia , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Modelos Estadísticos , Mortalidad , Estudios Prospectivos , Resultado del Tratamiento
5.
Presse Med ; 39(10): 1049-57, 2010 Oct.
Artículo en Francés | MEDLINE | ID: mdl-20850262

RESUMEN

Mucous membrane pemphigoid belongs to the family of sub-epidermal bullous diseases and is clinically characterized by mucosal involvement leading to fibrosis and scarring. Cutaneous involvement is unfrequent and oral mucosa and conjunctivas are the most frequently involves mucosa. Treatment relies on anti-inflammatory and immunosuppressive drugs. The main goal is the limitation of the fibrosing potential of the autoimmune deposits within various mucous membranes.


Asunto(s)
Enfermedades Autoinmunes/diagnóstico , Enfermedades Autoinmunes/tratamiento farmacológico , Penfigoide Benigno de la Membrana Mucosa/diagnóstico , Penfigoide Benigno de la Membrana Mucosa/tratamiento farmacológico , Algoritmos , Antiinflamatorios/uso terapéutico , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales de Origen Murino , Enfermedades Autoinmunes/epidemiología , Enfermedades Autoinmunes/etiología , Ciclofosfamida/uso terapéutico , Dapsona/uso terapéutico , Árboles de Decisión , Diagnóstico Diferencial , Ensayo de Inmunoadsorción Enzimática , Técnica del Anticuerpo Fluorescente , Francia/epidemiología , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Inmunosupresores/uso terapéutico , Ácido Micofenólico/análogos & derivados , Ácido Micofenólico/uso terapéutico , Penfigoide Benigno de la Membrana Mucosa/epidemiología , Penfigoide Benigno de la Membrana Mucosa/etiología , Rituximab , Sulfasalazina/uso terapéutico , Factor de Necrosis Tumoral alfa/uso terapéutico
6.
Anticancer Res ; 30(1): 143-7, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20150629

RESUMEN

UNLABELLED: The large number of studies devoted to the effect of ultraviolet light on biological systems, contrasts with the lack of experimental data concerning the direct effects of visible light. It has been shown that blue light inhibited the growth of B16F10 melanoma cell lines and reduced the percentage of S phase cells. Yet these effects are poorly understood. MATERIALS AND METHODS: Two cell lines and irradiation with blue light were used. Cell mortality and a possible mechanism of action were investigated. RESULTS: Exposure of B16F10 melanoma and bovine endothelial cells to blue light (wavelength 450 nm, 10 J/cm(2) from a Waldman lamp) induced a rapid and large reduction in viability followed by the death of virtually all the irradiated cells within 24 h. These results led us to expose a patient with haemorrhagic cutaneous melanoma metastasis to blue light. Irradiation led to an immediate arrest of haemorrhage, an inhibition of tumour growth and extensive tumour necrosis 24h after irradiation. CONCLUSION: Exposure to blue light may offer new approaches to the treatment of superficial skin carcinomas in humans.


Asunto(s)
Células Endoteliales/efectos de la radiación , Melanoma Experimental/terapia , Fototerapia/métodos , Animales , Bovinos , Supervivencia Celular/efectos de la radiación , Células Endoteliales/citología , Células Endoteliales/metabolismo , Luz , Peroxidación de Lípido/efectos de la radiación , Melanoma Experimental/metabolismo , Melanoma Experimental/patología , Ratones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA